PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 24, 2026JAMA Cardiology3 citations

Antiplatelet Therapy After CABG—Toward a Mechanistic Approach

View Full Paper
SSSigrid SandnerRCRaffaele De CaterinaMGMario Gaudino

Key Result

A biology-driven approach to antiplatelet therapy after coronary artery bypass graft surgery is proposed to align treatment with patients' evolving thrombotic risk.

Key Points

  • To explore a biology-driven approach to antiplatelet therapy in relation to thrombotic risk following CABG surgery.
  • Discussion of biological mechanisms related to thrombotic risk.
  • Analysis of current antiplatelet therapy strategies post-CABG.
  • Proposes an innovative, mechanistic framework for antiplatelet therapy.
  • Highlights the need for personalized treatment based on evolving thrombotic risks.

Structured PICO

P
Population
Patients after coronary artery bypass graft (CABG) surgery
I
Intervention
Antiplatelet therapy aligned with evolving thrombotic risk (biology-driven concept)

Proposes a novel, biology-driven approach to align antiplatelet therapy with evolving thrombotic risk following CABG surgery.

Abstract

This Viewpoint discusses a novel, biology-driven concept aligning antiplatelet therapy with evolving thrombotic risk after coronary artery bypass graft (CABG) surgery.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sandner et al. (2026) studied this question. A biology-driven approach to antiplatelet therapy after coronary artery bypass graft surgery is proposed to align treatment with patients' evolving thrombotic risk.

synapsesocial.com/papers/69eb0bfa553a5433e34b582ehttps://doi.org/10.1001/jamacardio.2026.0840
Ask AI
Helpful
Bookmark
Share
View Full Paper